Sort
34,240 grants matching “atherosclerosis”
Hearing loss, brain aging, and speech-in-noise performance in the ACHIEVE study
$618,171Frank R Lin · Johns Hopkins University · R01 · FY2021 · AG
Long-Term Cardiovascular Sequelae of Cancer Immunotherapies
$618,167Javid J Moslehi · University Of California, San Francisco · R01 · FY2023 · HL
PREVALENCE &PROGRESSION OF SUBCLINICAL ATHEROSCLEROSIS
$618,099University Of Pittsburgh At Pittsburgh · R01 · FY2001 · HL
Role of Femoral Atherosclerosis in Functional Status, CVD Events, and Mortality
$618,059Christina L. Wassel · University Of California, San Diego · R01 · FY2012 · HL
Diabetes Prevention Program Outcomes Study - Phase 2
$617,958F. Xavier Pi-Sunyer · St. Luke'S-Roosevelt Inst For Hlth Scis · U01 · FY2012 · DK
Senescence dysregulates of inflammation-resolution programs in atherosclerosis
$617,817Gabrielle Fredman · Albany Medical College · R01 · FY2023 · HL
Senescence dysregulates of inflammation-resolution programs in atherosclerosis
$617,817Gabrielle Fredman · Albany Medical College · R01 · FY2022 · HL
Senescence dysregulates of inflammation-resolution programs in atherosclerosis
$617,817Gabrielle Fredman · Albany Medical College · R01 · FY2021 · HL
Downmodulating Monocyte/Macrophage Activation for HAND
$617,721Ronald G Collman · University Of Pennsylvania · R01 · FY2013 · MH
Gender Obesity C-Reactive Protein and Oxidative Stress
$617,680University Of California Berkeley · R01 · FY2004 · DK
Critical Mediators of Inflammation Resolution and Immune Memory in Atherosclerosis
$617,679Amanda C Doran · Vanderbilt University Medical Center · R01 · FY2024 · HL
Integrating Coronary Atherosclerosis with Physiologic Features for Optimized Risk Stratification
$617,597Peter Howard Stone · Brigham And Women'S Hospital · R01 · FY2021 · HL
Identification of Genes Influencing Total Antioxidant Status
$617,587John Blangero · Texas Biomedical Research Institute · R01 · FY2009 · HL
Health Outcomes of Discontinuing Aspirin in Older Adults with Alzheimer's Disease and Related Dementias
$617,564Carolyn Timberlake Thorpe · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AG
Identification of Genes Influencing Total Antioxidant Status
$617,454John Blangero · Texas Biomedical Research Institute · R01 · FY2010 · HL
Development of integrated OCT/US/PAT system for intravascular Imaging
$617,366Zhongping Chen · University Of California-Irvine · R01 · FY2025 · HL
Comprehensive functional genomic analysis of the multi-disease associated CDKN2A/B locus
$617,273Gang Li · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AG
ABCG1 Function in Diabetes
$617,191Catherine C Hedrick · La Jolla Institute For Immunology · R01 · FY2012 · HL
ABCG1 Function in Diabetes
$617,191Catherine C Hedrick · La Jolla Institute For Immunology · R01 · FY2011 · HL
Diabetes-mediated effects on myeloid precursors and vascular complications
$617,182Edward A Fisher · New York University School Of Medicine · R01 · FY2015 · DK
Airway Tree Subtyping on Large Cohorts of CT Images for COPD Risk
$616,904Andrew Francis Laine · Columbia University Health Sciences · R01 · FY2023 · HL
Cholesterol efflux, CHIP and inflammasome activation
$616,875Alan Richard Tall · Columbia University Health Sciences · R01 · FY2025 · HL
Cholesterol efflux, CHIP and inflammasome activation
$616,875Alan Richard Tall · Columbia University Health Sciences · R01 · FY2023 · HL
Diabetes Prevention Program Outcomes Study - Phase 2
$616,860Robert E Ratner · Medstar Health Research Institute · U01 · FY2009 · DK
Health Outcomes of Discontinuing Aspirin in Older Adults with Alzheimer's Disease and Related Dementias
$616,553Carolyn Timberlake Thorpe · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AG